Sansure Biotech(688289) 证券时报网·2025-03-06 19:36Group 1 - The government work report emphasizes shifting economic policies towards improving people's livelihoods and promoting consumption, aiming to boost economic circulation and upgrade industries through consumption [1] - The chairman of Shengxiang Biotechnology, Dai Lizhong, highlights the importance of personalized treatment solutions and digital empowerment in healthcare to enhance disease treatment, prevention, and health management [1][2] - The health consumption market in China is expected to experience significant growth, driven by increasing demand for health-related services and products, particularly in the context of an aging population [2] Group 2 - There is a current mismatch in the health consumption sector, with a concentration on health products and beauty services, while high-quality products and services for disease prevention and personalized healthcare are lacking [2] - Recommendations include incorporating health consumption into national consumption promotion policies, enhancing life science innovation, and improving policy and financial support systems to accelerate the growth of the life science industry [2] - The global life science industry is undergoing a technological revolution, presenting opportunities for Chinese companies to expand internationally, with a focus on "technology + service" output [3]